![Zoya Gluzman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zoya Gluzman
Geen lopende functies
Loopbaan van Zoya Gluzman
Eerdere bekende functies van Zoya Gluzman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VESSL Therapeutics Ltd.
![]() VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Corporate Officer/Principal | - | - |
GeneGrafts Ltd.
![]() GeneGrafts Ltd. BiotechnologyHealth Technology GeneGrafts Ltd. develops proprietary technology for modulating excitable tissues. Its technology is used for the treatment of cardiac arrhythmias, Parkinson's disease and other neurological disorders. The company was founded by Yair Feld, Lior Gepstein, Shimon Marom and Meira Melamed Frank in 2003 and is headquartered in Haifa, Israel. | Hoofd Techniek/Wetenschap/O&O | 01-01-2005 | - |
Opleiding van Zoya Gluzman
Technion-Israel Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
Israël | 4 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
GeneGrafts Ltd.
![]() GeneGrafts Ltd. BiotechnologyHealth Technology GeneGrafts Ltd. develops proprietary technology for modulating excitable tissues. Its technology is used for the treatment of cardiac arrhythmias, Parkinson's disease and other neurological disorders. The company was founded by Yair Feld, Lior Gepstein, Shimon Marom and Meira Melamed Frank in 2003 and is headquartered in Haifa, Israel. | Health Technology |
VESSL Therapeutics Ltd.
![]() VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
- Beurs
- Insiders
- Zoya Gluzman
- Ervaring